Marc Loire (544437)
Slow GrowerScore breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹70 |
| Market Cap | ₹49.7 Cr |
| P/E Ratio | 13.81 |
| ROCE | 72.75% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -48.47% |
| Debt/Equity | — |
| Sales Growth | 1.06% |
| Sector | Consumer Durables |
Strengths
- ROCE of 72.75% suggests efficient use of capital, if sustainable.
- Trailing P/E of 13.81 gives a modest earnings yield of about 7.2%.
- Latest quarter is still profitable: ₹1 Cr net profit on ₹15 Cr sales.
- Low market cap of ₹50 Cr leaves scope for growth if the business revives.
Concerns
- Profit growth is deeply negative at -48.47%.
- Sales growth is almost flat at 1.06%, showing no momentum.
- Piotroski F-Score of 4/9 points to weak fundamental health.
- Zero dividend yield and missing data on book value, debt, and promoter holding reduce confidence.
AI Analysis
When I look at Marc Loire, I am reminded that a cheap-looking stock can still be an expensive mistake. The trailing P/E of 13.81 translates to an earnings yield of roughly 7.2%, which is not terrible, but it comes with a serious caveat: profit growth has collapsed by 48.47% while sales growth is barely 1.06%. In other words, this business is running harder just to stand still. The latest quarter shows sales of ₹15 Cr and net profit of ₹1 Cr, a margin of about 6.7%, but the trend is concerning. A Piotroski score of 4 out of 9 suggests weak operational health—this is not a company with growing profitability or strengthening balance sheet signals. The high ROCE of 72.75% initially catches my eye, but without book value, debt/equity, or promoter holding data, I cannot verify whether that return is sustainable or simply a by-product of a thin equity base. Footwear is a competitive, low-moat sector in India, with shifting consumer preferences and unorganised competition. There is no dividend yield, so the investor's return depends entirely on future earnings, yet earnings are shrinking. The PEG ratio of 13.03 looks absurd and confirms that growth is not justifying the multiple. This is not a wonderful business at a fair price; it may be an ordinary business at an uncertain price. I would need evidence of sales traction, margin stabilisation, and a recovery in profit growth before considering an investment. In Graham's terms, there is no visible margin of safety here. I will wait.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer